Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Financing Activities (2017 - 2021)

Historic Cash from Financing Activities for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $38.0 million.

  • Cogent Biosciences' Cash from Financing Activities fell 6888.22% to $38.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $38.0 million, marking a year-over-year decrease of 8364.49%. This contributed to the annual value of $214.5 million for FY2024, which is 3113.38% up from last year.
  • According to the latest figures from Q4 2021, Cogent Biosciences' Cash from Financing Activities is $38.0 million, which was down 6888.22% from $55000.0 recorded in Q3 2021.
  • Cogent Biosciences' Cash from Financing Activities' 5-year high stood at $122.1 million during Q4 2020, with a 5-year trough of -$734000.0 in Q4 2017.
  • Over the past 5 years, Cogent Biosciences' median Cash from Financing Activities value was $85000.0 (recorded in 2019), while the average stood at $24.3 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 56363.64% in 2020, then tumbled by 21643.84% in 2021.
  • Cogent Biosciences' Cash from Financing Activities (Quarter) stood at -$734000.0 in 2017, then skyrocketed by 153.81% to $395000.0 in 2018, then plummeted by 75.44% to $97000.0 in 2019, then soared by 125813.4% to $122.1 million in 2020, then crashed by 68.88% to $38.0 million in 2021.
  • Its Cash from Financing Activities stands at $38.0 million for Q4 2021, versus $55000.0 for Q3 2021 and -$85000.0 for Q1 2021.